Genomics - G2 Intelligence

Expert Q&A: What’s Next in Next-Generation Sequencing?

by Rachel Muenz | Nov 24, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Inside the Diagnostics Industry-dtet, Testing Trends-dtet

Crystal Girod, MSc, of Beckman Coulter Life Sciences discusses recent developments in NGS and their impact on clinical diagnostics.

This content is for Paid Members only.
Register

Already a member? Log in here

ACMG Statements Highlight Ongoing Concerns around Polygenic Risk Scores

by Miriam Bergeret, MSc | May 3, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Special Focus-dtet

Though there are currently no clinical guidelines for their use, PRSs are being widely used in health care.

This content is for Paid Members only.
Register

Already a member? Log in here

New Partnership Aims to Improve Genomic Variant Interpretation

by Rachel Muenz | Jun 8, 2022 | Articles, News, Open Content

Agilent and Genomenon team up to bring users more effective software and search tools for making a genetic diagnosis.

Illumina and Precision Health Team Up for Population Study

by Rachel Muenz | Jun 1, 2022 | Articles, News, Open Content

Partnership will make use of Illumina’s capabilities and expertise in large-scale genomic sequencing and quickly generate high-quality data.

Singleron Extends Reach outside of China with Acquisition of Proteona

by Rachel Muenz | Mar 14, 2022 | Articles, News, Open Content

Last week, Chinese genomics company Singleron Biotechnologies, which develops single-cell multi-omics platform technologies and helps translate them to the clinic, announced it had acquired Proteona Pte. Ltd. Based in Singapore, Proteona is also focused on the...

Expert Q&A: What’s Next in Next-Generation Sequencing?

ACMG Statements Highlight Ongoing Concerns around Polygenic Risk Scores

New Partnership Aims to Improve Genomic Variant Interpretation

Illumina and Precision Health Team Up for Population Study

Singleron Extends Reach outside of China with Acquisition of Proteona

Log In